Menin inhibition as a new therapeutic option for the myeloproliferative neoplasms
John D. Crispino(St. Jude Children's Research Hospital), Gerard M. McGeehan, Bridget K. Marcellino(Mount Sinai Medical Center), Robert S. Hoffman(New York City Department of Health and Mental Hygiene), Rashid Mehmood(Beijing Normal University), Jeremy Q. Wen(St. Jude Children's Research Hospital), Trent Hall(International Society for Experimental Hematology), Laura J. Janke(St. Jude Children's Research Hospital), Amber Broadhurst(St. Jude Children's Research Hospital), Sandeep Gurbuxani(University of Chicago), John Mascarenhas(Icahn School of Medicine at Mount Sinai), Anitria Cotton(International Society for Experimental Hematology)
Cited by 0
Related Papers
Survival Function of the FADD-CASPASE-8-cFLIPL Complex
|Cell Reports|2012|328